UBS cuts Brown Forman stock target to $30, maintains neutral

Published 09/06/2025, 14:58
UBS cuts Brown Forman stock target to $30, maintains neutral

On Monday, UBS analyst Peter Grom revised the price target for Brown Forman (NYSE:BFb) (NYSE:BF-B) shares, reducing it to $30.00 from the previous $38.00, while sustaining a Neutral stock rating. The adjustment follows Brown Forman’s reported challenges at the close of fiscal year 2025, with future projections indicating a continuation of these difficulties.

Brown Forman’s fourth-quarter results and outlook for the upcoming year did not meet market expectations, causing the stock to fall by 18% on the day of the announcement, a stark contrast to the 1% decline in the Consumer Staples Select Sector SPDR Fund (XLP). The company’s performance raised concerns among investors about whether the current issues are permanent rather than temporary.

In his statement, Grom noted that prior to the earnings report, there was a belief that the worst outcomes had already been factored into the stock price and that potential cost savings might lead to better profitability. However, the actual earnings report did not support this optimism, leading to a reevaluation of the stock’s long-term growth prospects.

Despite the drop, Brown Forman’s valuation remains attractive, trading at approximately 17 times earnings, which is below its five-year average of around 33 times. Even with its valuation appearing favorable, Grom expressed that the stock is likely to stay within a certain range until there is clearer evidence of revenue growth.

UBS’s revised price target and maintained rating reflect a cautious stance on Brown Forman’s stock, acknowledging the company’s conservative outlook but also pointing to the challenges in predicting its fundamental trajectory amid ongoing industry trends that have not met expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.